Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Greenphire surveyed the clinical trials market worldwide to identify processes, challenges and preferences related to global site payments and budget development, negotiation and fair market value data.
A total of 189 industry representatives from global sponsors and CROs – inclusive of various roles spanning study management/clin ops, site payments, clinical forecasting & analytics and more – participated in this study, providing insights into the state of the industry.
Overall, 95% of all survey respondents agreed that it is important for their organization to be viewed by research sites as “Sponsor of Choice”.